These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 22745483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P, Genoud N, Prinz M, Maissen M, Rülicke T, Zurbriggen A, Raeber AJ, Aguzzi A.
    Cell; 2003 Apr 04; 113(1):49-60. PubMed ID: 12679034
    [Abstract] [Full Text] [Related]

  • 3. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
    Zhang X, Pan YH, Chen Y, Pan C, Ma J, Yuan C, Yu G, Ma J.
    J Biol Chem; 2021 Nov 04; 297(5):101344. PubMed ID: 34710372
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human prion protein inhibits prion propagation in vitro.
    Yuan J, Zhan YA, Abskharon R, Xiao X, Martinez MC, Zhou X, Kneale G, Mikol J, Lehmann S, Surewicz WK, Castilla J, Steyaert J, Zhang S, Kong Q, Petersen RB, Wohlkonig A, Zou WQ.
    Sci Rep; 2013 Oct 09; 3():2911. PubMed ID: 24105336
    [Abstract] [Full Text] [Related]

  • 5. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K, Miyata H, Yamaguchi Y, Imamura M, Okazaki M, Pasiana AD, Chida J, Hara H, Atarashi R, Watanabe H, Kondoh G, Sakaguchi S.
    Int J Mol Sci; 2020 Oct 01; 21(19):. PubMed ID: 33019549
    [Abstract] [Full Text] [Related]

  • 6. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
    Miller MB, Geoghegan JC, Supattapone S.
    PLoS Pathog; 2011 Jul 01; 7(7):e1002128. PubMed ID: 21779169
    [Abstract] [Full Text] [Related]

  • 7. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I, Hässig R, Haïk S, Simon S, Grassi J, Fonta C, Faucheux BA, Moya KL.
    Biol Chem; 2006 Mar 01; 387(3):297-300. PubMed ID: 16542151
    [Abstract] [Full Text] [Related]

  • 8. Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.
    Khalifé M, Reine F, Paquet-Fifield S, Castille J, Herzog L, Vilotte M, Moudjou M, Moazami-Goudarzi K, Makhzami S, Passet B, Andréoletti O, Vilette D, Laude H, Béringue V, Vilotte JL.
    J Virol; 2016 Feb 01; 90(3):1638-46. PubMed ID: 26608316
    [Abstract] [Full Text] [Related]

  • 9. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
    Basu S, Mohan ML, Luo X, Kundu B, Kong Q, Singh N.
    Mol Biol Cell; 2007 Sep 01; 18(9):3302-12. PubMed ID: 17567949
    [Abstract] [Full Text] [Related]

  • 10. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE, Hughson A, Vascellari S, Priola SA, Sakudo A, Onodera T, Baron GS.
    J Virol; 2017 Jan 15; 91(2):. PubMed ID: 27847358
    [Abstract] [Full Text] [Related]

  • 11. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
    Hara H, Okemoto-Nakamura Y, Shinkai-Ouchi F, Hanada K, Yamakawa Y, Hagiwara K.
    J Virol; 2012 May 15; 86(10):5626-36. PubMed ID: 22398286
    [Abstract] [Full Text] [Related]

  • 12. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM, Harrison CF, Guo B, Masters CL, Barnham KJ, Lawson VA, Hill AF.
    J Virol; 2014 Mar 15; 88(5):2690-703. PubMed ID: 24352465
    [Abstract] [Full Text] [Related]

  • 13. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR, Whitehouse IJ, Hooper NM.
    PLoS Pathog; 2009 Nov 15; 5(11):e1000666. PubMed ID: 19936054
    [Abstract] [Full Text] [Related]

  • 14. Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.
    Harrison CF, Lawson VA, Coleman BM, Kim YS, Masters CL, Cappai R, Barnham KJ, Hill AF.
    J Biol Chem; 2010 Jun 25; 285(26):20213-23. PubMed ID: 20356832
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E, Makarava N, Savtchenko R, D'Azzo A, Baskakov IV.
    PLoS Pathog; 2014 Sep 25; 10(9):e1004366. PubMed ID: 25211026
    [Abstract] [Full Text] [Related]

  • 17. Copper binding to PrPC may inhibit prion disease propagation.
    Hijazi N, Shaked Y, Rosenmann H, Ben-Hur T, Gabizon R.
    Brain Res; 2003 Dec 12; 993(1-2):192-200. PubMed ID: 14642846
    [Abstract] [Full Text] [Related]

  • 18. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
    Akasaka K, Maeno A, Murayama T, Tachibana H, Fujita Y, Yamanaka H, Nishida N, Atarashi R.
    Prion; 2014 Dec 12; 8(4):314-8. PubMed ID: 25482603
    [Abstract] [Full Text] [Related]

  • 19. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA, Telling GC.
    Methods Mol Biol; 2017 Dec 12; 1658():219-252. PubMed ID: 28861793
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.